About: How to approach and treat viral infections in ICU patients

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: How to approach and treat viral infections in ICU patients Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	How to approach and treat viral infections in ICU patients
Creator	Tsiodras, Sotirios Kelesidis, Theodoros Mastoris, Ioannis Metsini, Aliki
Source	Medline; PMC
abstract	Patients with severe viral infections are often hospitalized in intensive care units (ICUs) and recent studies underline the frequency of viral detection in ICU patients. Viral infections in the ICU often involve the respiratory or the central nervous system and can cause significant morbidity and mortality especially in immunocompromised patients. The mainstay of therapy of viral infections is supportive care and antiviral therapy when available. Increased understanding of the molecular mechanisms of viral infection has provided great potential for the discovery of new antiviral agents that target viral proteins or host proteins that regulate immunity and are involved in the viral life cycle. These novel treatments need to be further validated in animal and human randomized controlled studies.
has issue date	2014-11-28(xsd:dateTime)
bibo:doi	10.1186/1471-2334-14-321
bibo:pmid	25431007
has license	cc-by
sha1sum (hex)	3b4888c664b3d2fa758325160b185a453b6f8bb4
schema:url	https://doi.org/10.1186/1471-2334-14-321
resource representing a document's title	How to approach and treat viral infections in ICU patients
has PubMed Central identifier	PMC4289200
has PubMed identifier	25431007
schema:publication	BMC Infect Dis
resource representing a document's body	covid:3b4888c664b3d2fa758325160b185a453b6f8bb4#body_text
is schema:about of	named entity 'INTENSIVE CARE UNITS' named entity 'VALIDATED' named entity 'GREAT' named entity 'MORBIDITY AND MORTALITY' named entity 'MOLECULAR' named entity 'RECENT' named entity 'STUDIES' named entity 'IMMUNITY' named entity 'VIRAL INFECTION' named entity 'NEW' named entity 'VIRAL LIFE CYCLE' named entity 'VIRAL PROTEINS' named entity 'HUMAN' named entity 'VIRAL INFECTIONS' named entity 'NEED' named entity 'PROTEINS' named entity 'HOSPITALIZED' named entity 'validated' named entity 'viral infections' named entity 'human' named entity 'viral life cycle' named entity 'ICUs' named entity 'These' named entity 'therapy' named entity 'Patients' named entity 'How' named entity 'PATIENTS' named entity 'MECHANISMS' named entity 'CAUSE' named entity 'HOST' named entity 'INCREASED' named entity 'INVOLVED' named entity 'NOVEL' named entity 'UNDERSTANDING' named entity 'PATIENTS' named entity 'TREATMENTS' named entity 'THESE' named entity 'ICU' named entity 'IMMUNOCOMPROMISED PATIENTS' named entity 'SUPPORTIVE CARE' named entity 'HOW' named entity 'VIRAL INFECTIONS' covid:arg/3b4888c664b3d2fa758325160b185a453b6f8bb4 named entity 'APPROACH' named entity 'TREAT' named entity 'SEVERE VIRAL INFECTIONS' named entity 'DISCOVERY' named entity 'ANTIVIRAL AGENTS' named entity 'ANTIVIRAL THERAPY' named entity 'CENTRAL NERVOUS SYSTEM' named entity 'ANIMAL' named entity 'RANDOMIZED CONTROLLED STUDIES' named entity 'TARGET' named entity 'PROVIDED' named entity 'REGULATE' named entity 'FREQUENCY' named entity 'SIGNIFICANT' named entity 'POTENTIAL' named entity 'ICU' named entity 'AVAILABLE' named entity 'RESPIRATORY' named entity 'THERAPY' named entity 'VIRAL DETECTION' named entity 'Viral infections' named entity 'severe' named entity 'molecular mechanisms' named entity 'proteins' named entity 'viral' named entity 'morbidity' named entity 'ICU' named entity 'patients' named entity 'randomized controlled studies' named entity 'viral life cycle' named entity 'frequency' named entity 'GBS' named entity 'virus' named entity 'proinflammatory' named entity 'prognosis'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software